Pharmacokinetic study in rats after single intravenous and oral administrations of [14C]-ITF-296. 1998

C Giachetti, and M Bertolino, and S Canali, and E Lombardini, and M V Monzani, and A Sala, and G Zanolo
Istituto di Ricerche Biomediche A. Marxer, RBM S.p.A., Colleretto Giacosa (TO), Italy.

Pharmacokinetics of [14C]-ITF-296 and its metabolites, ITF-1124 and ITF-1577, were studied in rats after a single intravenous (2.5 mg/kg) and oral (10 mg/kg) administration. Radioactivity was measured by LSC while unchanged drug and its metabolites in plasma were assayed by an HPLC-UV method. The absorption of [14C]-ITF-296 after oral administration is practically complete. Elimination of radioactivity occurs mainly in urine (higher than 80%) and the recovery of the dose (higher than 95%) takes place up to 96 h after both treatments. Both by i.v. and p.o. route the results show that the radioactivity is largely excreted in the bile and reabsorbed in the intestine. The tissue distribution study indicates that there is no accumulation or localization of radioactivity in the major organs or blood and no radioactivity levels are found 96 h after either treatment. In addition, whole body autoradiography confirms the tissue distribution pattern, showing no differences between albino and pigmented rats.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D009566 Nitrates Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. Nitrate
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001345 Autoradiography The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed) Radioautography
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary

Related Publications

C Giachetti, and M Bertolino, and S Canali, and E Lombardini, and M V Monzani, and A Sala, and G Zanolo
January 1995, Journal of cardiovascular pharmacology,
C Giachetti, and M Bertolino, and S Canali, and E Lombardini, and M V Monzani, and A Sala, and G Zanolo
May 1995, Biopharmaceutics & drug disposition,
C Giachetti, and M Bertolino, and S Canali, and E Lombardini, and M V Monzani, and A Sala, and G Zanolo
November 1973, Journal of pharmaceutical sciences,
C Giachetti, and M Bertolino, and S Canali, and E Lombardini, and M V Monzani, and A Sala, and G Zanolo
April 2012, Planta medica,
C Giachetti, and M Bertolino, and S Canali, and E Lombardini, and M V Monzani, and A Sala, and G Zanolo
January 1989, The European respiratory journal,
C Giachetti, and M Bertolino, and S Canali, and E Lombardini, and M V Monzani, and A Sala, and G Zanolo
June 1992, Arzneimittel-Forschung,
C Giachetti, and M Bertolino, and S Canali, and E Lombardini, and M V Monzani, and A Sala, and G Zanolo
September 2006, The Journal of pharmacy and pharmacology,
C Giachetti, and M Bertolino, and S Canali, and E Lombardini, and M V Monzani, and A Sala, and G Zanolo
April 2008, Biopharmaceutics & drug disposition,
C Giachetti, and M Bertolino, and S Canali, and E Lombardini, and M V Monzani, and A Sala, and G Zanolo
January 1995, Journal of cardiovascular pharmacology,
C Giachetti, and M Bertolino, and S Canali, and E Lombardini, and M V Monzani, and A Sala, and G Zanolo
April 1993, Biopharmaceutics & drug disposition,
Copied contents to your clipboard!